Zacks Investment Research on MSN
OraSure files for FDA review of molecular self-test & Colli-Pee device
OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at ...
The rapid molecular chlamydia and gonorrhea self-test provides results in 30 minutes from a self-collected swab sample, the firm said.
Presently, a proposal is before CMS to drastically cut reimbursement for point-of-care test (POCT) devices used in urine drug screening. Outside interests are proposing these drastic cuts to CMS based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback